1323 related articles for article (PubMed ID: 11336929)
21. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
Brown DM; Michels M; Kaiser PK; Heier JS; Sy JP; Ianchulev T;
Ophthalmology; 2009 Jan; 116(1):57-65.e5. PubMed ID: 19118696
[TBL] [Abstract][Full Text] [Related]
22. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.
; ;
Retina; 2002 Feb; 22(1):6-18. PubMed ID: 11884872
[TBL] [Abstract][Full Text] [Related]
23. [Photodynamic therapy in age-related macular degeneration--results of one year observation].
Wykrota H; Gierek-Łapińska A
Klin Oczna; 2002; 104(3-4):239-43. PubMed ID: 12608309
[TBL] [Abstract][Full Text] [Related]
24. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
Azab M; Benchaboune M; Blinder KJ; Bressler NM; Bressler SB; Gragoudas ES; Fish GE; Hao Y; Haynes L; Lim JI; Menchini U; Miller JW; Mones J; Potter MJ; Reaves A; Rosenfeld PJ; Strong A; Su XY; Slakter JS; Schmidt-Erfurth U; Sorenson JA; ;
Retina; 2004 Feb; 24(1):1-12. PubMed ID: 15076937
[TBL] [Abstract][Full Text] [Related]
25. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL
Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
[TBL] [Abstract][Full Text] [Related]
26. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C
Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization.
Rosenblatt BJ; Shah GK; Blinder K
Retina; 2005 Jan; 25(1):33-7. PubMed ID: 15655438
[TBL] [Abstract][Full Text] [Related]
28. Verteporfin therapy of subfoveal occult choroidal neovascularization in AMD using delayed light application: one-year results of the VALIO Study.
Rosenfeld PJ; Boyer DS; Bressler NM; Fish G; Grizzard WS; Hao Y; Hnik P; Hudson HL; Singerman L; Slakter JS;
Am J Ophthalmol; 2007 Dec; 144(6):970-972. PubMed ID: 18036873
[TBL] [Abstract][Full Text] [Related]
29. Verteporfin therapy in age-related macular degeneration (VAM): an open-label multicenter photodynamic therapy study of 4,435 patients.
Bessler NM;
Retina; 2004 Aug; 24(4):512-20. PubMed ID: 15300071
[TBL] [Abstract][Full Text] [Related]
30. Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.
Nicolò M; Ghiglione D; Lai S; Nasciuti F; Cicinelli S; Calabria G
Retina; 2006 Jan; 26(1):58-64. PubMed ID: 16395140
[TBL] [Abstract][Full Text] [Related]
31. Effect of adjunctive diclofenac with verteporfin therapy to treat choroidal neovascularization due to age-related macular degeneration: phase II study.
; Boyer DS; Beer PM; Joffe L; Koester JM; Marx JL; Weisberger A; Yoser SL
Retina; 2007; 27(6):693-700. PubMed ID: 17621177
[TBL] [Abstract][Full Text] [Related]
32. Verteporfin therapy in occult with no classic CNV due to AMD: results of the Photodynamic Therapy in Occult-Only Lesions study.
Soubrane G; Harding SP; Wolf S; Weichselberger A
Eye (Lond); 2009 Apr; 23(4):791-800. PubMed ID: 18583995
[TBL] [Abstract][Full Text] [Related]
33. Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No 4.
Rubin GS; Bressler NM;
Retina; 2002 Oct; 22(5):536-44. PubMed ID: 12441717
[TBL] [Abstract][Full Text] [Related]
34. Randomized multicenter trial of more intense and standard early verteporfin treatment of neovascular age-related macular degeneration.
Schmidt-Erfurth U; Sacu S;
Ophthalmology; 2008 Jan; 115(1):134-40. PubMed ID: 18166408
[TBL] [Abstract][Full Text] [Related]
35. One-year results of photodynamic therapy for small predominantly classic choroidal neovascular membranes secondary to age-related macular degeneration.
Doyle E; Khanwala M; Shah SP; Ong DG; Casswell AG
Eur J Ophthalmol; 2007; 17(5):760-7. PubMed ID: 17932852
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
[TBL] [Abstract][Full Text] [Related]
37. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
[TBL] [Abstract][Full Text] [Related]
38. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
Schmidt-Erfurth UM; Michels S
Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
[TBL] [Abstract][Full Text] [Related]
39. Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration.
Slakter JS; Bochow TW; D'Amico DJ; Marks B; Jerdan J; Sullivan EK; Robertson SM; Slakter JS; Sullins G; Zilliox P;
Ophthalmology; 2006 Jan; 113(1):3-13. PubMed ID: 16368146
[TBL] [Abstract][Full Text] [Related]
40. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
